speb/financial-data huggingface dataset:
Financial ratios for BTBD — quarterly report dated 2025-03-31
Total revenue: 3231073
Gross profit: 812847
Operating income: -292196
Net income: -329849
Capital expenditures: 89865
Operating cash flow: -306739
Depreciation & amortization: 156395
Net tangible assets: 5521984
Owner earnings: -263319
Return on net tangible assets (%): -4.768557822695611
Buffett classification: The Gruesome
Stock price: 1.27
Shares outstanding: 6184724
Book value: 6666378
P/B ratio: 1.1782409398326947
Market cap (USD): 7854599.48
Debt to equity: 0.5562666863475189
Current ratio: 4.604244012107455
Quick ratio: 4.358204701088163
Interest coverage ratio: -13.556462837524357
COGS to revenue (%): 74.8428153743354
SG&A to revenue (%): 23.544129148428404
Free cash flow (dilution-adjusted): -462104
Buyback yield (%): 0
Retained earnings: -4690948
Inventory turnover: 10.150079539301649
Receivables turnover: 91.19338996923598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.9115799264043756
FCF margin (%): -14.301874330911124
Rule of 40 score: -14.301874330911124
Financial ratios for BTBD — quarterly report dated 2025-06-30
Total revenue: 3779690
Gross profit: 1155867
Operating income: -75121
Net income: 55031
Capital expenditures: 0
Operating cash flow: 384362
Depreciation & amortization: 144725
Net tangible assets: 5656216
Owner earnings: 199756
Return on net tangible assets (%): 3.5316190187927763
Buffett classification: The Gruesome
Stock price: 1.32
P/E ratio: 37.087440170085955
Shares outstanding: 6184724
Book value: 6784144
P/B ratio: 1.2033700463905248
Market cap (USD): 8163835.680000001
Debt to equity: 0.5337029992287899
Current ratio: 4.668554652524568
Quick ratio: 4.215005073769327
Effective tax rate (%): 0
Interest coverage ratio: -3.8425063938618926
COGS to revenue (%): 69.41899997089709
SG&A to revenue (%): 22.04090811680323
Free cash flow (dilution-adjusted): 321627
Buyback yield (%): 0
Retained earnings: -4635917
Inventory turnover: 4.863660039853562
Receivables turnover: 5.209413548342637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7492006438731322
FCF margin (%): 8.509348650286135
Revenue growth (%): 16.979405912525035
Rule of 40 score: 25.48875456281117
Financial ratios for BTBD — quarterly report dated 2025-09-30
Total revenue: 3853682
Gross profit: 1386955
Operating income: 492811
Net income: 914975
Capital expenditures: 63401
Operating cash flow: 325177
Depreciation & amortization: 151010
Net tangible assets: 6608896
Owner earnings: 1002584
Return on net tangible assets (%): 15.170219050201425
Capex to operating income (%): 12.865175493241832
Buffett classification: The Great
Stock price: 1.98
P/E ratio: 19.129297219275898
Shares outstanding: 6184724
Book value: 7724453
P/B ratio: 1.5853230668890081
Market cap (USD): 12245753.52
Debt to equity: 0.48469089008632715
Current ratio: 6.804035909397701
Quick ratio: 6.225883118028758
Effective tax rate (%): 0
Interest coverage ratio: 30.076960634726884
COGS to revenue (%): 64.00961470095353
SG&A to revenue (%): 13.26972490205471
Free cash flow (dilution-adjusted): 236442
Buyback yield (%): 0
Retained earnings: -3720942
Inventory turnover: 4.376422894045845
Receivables turnover: 4.843207387820351
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.494951319158499
FCF margin (%): 6.135482896616794
Revenue growth (%): 1.9576208630866552
Rule of 40 score: 8.09310375970345
Financial ratios for BTBD — quarterly report dated 2025-12-31
Total revenue: 2622184
Gross profit: 525414
Operating income: -517310
Net income: -1327996
Capital expenditures: 14841
Operating cash flow: -117924
Depreciation & amortization: 196574
Net tangible assets: 5316898
Owner earnings: -1146263
Return on net tangible assets (%): -21.558867595353533
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 6184724
Book value: 6418388
P/B ratio: 1.3393964902090678
Market cap (USD): 8596766.36
Debt to equity: 0.5701697996443967
Current ratio: 4.844081168695173
Quick ratio: 4.183381886604636
Interest coverage ratio: -21.436681584617936
COGS to revenue (%): 79.96273335509636
SG&A to revenue (%): 24.441114734892746
Free cash flow (dilution-adjusted): -125014
Buyback yield (%): 0
Retained earnings: -5048938
Inventory turnover: 2.6064867243546157
Receivables turnover: 48.10817157744101
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.429657279058523
FCF margin (%): -4.767552543986234
Revenue growth (%): -31.956399100911803
Rule of 40 score: -36.72395164489804
Financial ratios for BTBD — annual report dated 2025-12-31
Total revenue: 13486629
Gross profit: 3881083
Operating income: -391816
Net income: -687839
Capital expenditures: 172925
Operating cash flow: 284876
Depreciation & amortization: 648704
Net tangible assets: 5316898
Owner earnings: -212060
Return on net tangible assets (%): -3.9884158018453615
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 6184724
Book value: 6418388
P/B ratio: 1.3393964902090678
Market cap (USD): 8596766.36
Debt to equity: 0.5701697996443967
Current ratio: 4.844081168695173
Quick ratio: 4.183381886604636
Interest coverage ratio: -4.800431261562588
COGS to revenue (%): 71.22273475454838
SG&A to revenue (%): 20.361426120641415
Free cash flow (dilution-adjusted): -29049
Buyback yield (%): 0
Retained earnings: -5048938
Inventory turnover: 11.940617296688517
Receivables turnover: 247.4338421458188
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.112479164237293
FCF margin (%): -0.21539111070676
Revenue growth (%): -9.01842024594508
Rule of 40 score: -9.23381135665184
Financial ratios for BWIN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.11
Shares outstanding: 97489954
Market cap (USD): 3520362238.94
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWIN — annual report dated 2022-12-31
Total revenue: 969491000
Gross profit: 250046000
Operating income: 1209000
Net income: -41772000
Capital expenditures: 21979000
Operating cash flow: -2462000
Depreciation & amortization: 86358000
Net tangible assets: -1913874000
Owner earnings: 22607000
Capex to operating income (%): 1817.9487179487178
Buffett classification: The Gruesome
Stock price: 25.14
Shares outstanding: 97489954
Book value: 1140039000
P/B ratio: 2.1498364911726706
Market cap (USD): 2450897443.56
Debt to equity: 1.292366313784002
Current ratio: 1.104680165788051
Quick ratio: 1.104680165788051
Interest coverage ratio: 0.017010918505177847
COGS to revenue (%): 74.20852798014629
Free cash flow (dilution-adjusted): -71830000
Buyback yield (%): 0
Retained earnings: -96764000
Receivables turnover: 1.822378907953503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.0437571661860255
FCF margin (%): -7.409042476928615
Rule of 40 score: -7.409042476928615
Financial ratios for BWIN — annual report dated 2023-12-31
Total revenue: 1207739000
Gross profit: 296385000
Operating income: 18532000
Net income: -90141000
Capital expenditures: 21376000
Operating cash flow: 46000
Depreciation & amortization: 98402000
Net tangible assets: -1869300000
Owner earnings: -13115000
Capex to operating income (%): 115.34642780056119
Buffett classification: The Gruesome
Stock price: 24.02
Shares outstanding: 97489954
Book value: 1018882000
P/B ratio: 2.298311968490954
Market cap (USD): 2341708695.08
Debt to equity: 1.6015701523827097
Current ratio: 0.8959446121690664
Quick ratio: 0.8959446121690664
Interest coverage ratio: 0.1551249319884485
COGS to revenue (%): 75.45951567350231
Free cash flow (dilution-adjusted): -81338000
Buyback yield (%): 0
Retained earnings: -186905000
Receivables turnover: 1.9237915166034556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7507402277580244
FCF margin (%): -6.734733249485195
Revenue growth (%): 24.574544786903644
Rule of 40 score: 17.83981153741845
Financial ratios for BWIN — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1557000
Buffett classification: The Gruesome
Stock price: 49.8
Shares outstanding: 97489954
Market cap (USD): 4854999709.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWIN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 38.76
Shares outstanding: 97489954
Market cap (USD): 3778710617.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWIN — annual report dated 2024-12-31
Total revenue: 1376243000
Gross profit: 344195000
Operating income: 55699000
Net income: -24518000
Capital expenditures: 41049000
Operating cash flow: 51453000
Depreciation & amortization: 108924000
Net tangible assets: -1782645000
Owner earnings: 43357000
Capex to operating income (%): 73.69791199123861
Buffett classification: The Good
Stock price: 38.76
Shares outstanding: 97489954
Book value: 1008797000
P/B ratio: 3.7457591735899287
Market cap (USD): 3778710617.04
Debt to equity: 1.6265819585109789
Current ratio: 0.9716555885175979
Quick ratio: 0.9716555885175979
COGS to revenue (%): 74.99024518199184
Free cash flow (dilution-adjusted): -55099000
Buyback yield (%): 0
Retained earnings: -211423000
Receivables turnover: 1.9601920535083521
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2474707430142553
FCF margin (%): -4.003580762990257
Revenue growth (%): 13.952021090649552
Rule of 40 score: 9.948440327659295
Financial ratios for BWIN — quarterly report dated 2025-03-31
Total revenue: 408529000
Gross profit: 144686000
Operating income: 64078000
Net income: 24898000
Capital expenditures: 8933000
Operating cash flow: -63983000
Depreciation & amortization: 27465000
Net tangible assets: -1730343000
Owner earnings: 43430000
Return on net tangible assets (%): -2.5099069953182696
Capex to operating income (%): 13.940822123037547
Buffett classification: The Great
Stock price: 44.69
P/E ratio: 43.74674717105792
Shares outstanding: 97489954
Book value: 1048395000
P/B ratio: 4.155710437630855
Market cap (USD): 4356826044.26
Debt to equity: 1.5601419312377491
Current ratio: 1.1311306807225043
Quick ratio: 1.1311306807225043
Effective tax rate (%): 0
COGS to revenue (%): 64.58366480714956
Free cash flow (dilution-adjusted): -85719000
Buyback yield (%): 0
Retained earnings: -197484000
Receivables turnover: 0.5525575444111115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4501326240676455
FCF margin (%): -20.98235376191164
Rule of 40 score: -20.98235376191164
Financial ratios for BWIN — quarterly report dated 2025-06-30
Total revenue: 374312000
Gross profit: 105255000
Operating income: 25983000
Net income: -3164000
Capital expenditures: 11377000
Operating cash flow: -16721000
Depreciation & amortization: 27652000
Net tangible assets: -1715327000
Owner earnings: 13111000
Capex to operating income (%): 43.78632182580918
Buffett classification: The Good
Stock price: 42.81
P/E ratio: 192.02838551302108
Shares outstanding: 97489954
Book value: 1050369000
P/B ratio: 3.973408326730892
Market cap (USD): 4173544930.7400002
Debt to equity: 1.6227820889611175
Current ratio: 1.2304938316944403
Quick ratio: 1.2304938316944403
COGS to revenue (%): 71.88040992540982
Free cash flow (dilution-adjusted): -45050000
Buyback yield (%): 0
Retained earnings: -200648000
Receivables turnover: 0.445046857425493
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9512369778319281
FCF margin (%): -12.035414306781508
Revenue growth (%): -8.37565998986608
Rule of 40 score: -20.411074296647588
Financial ratios for BWIN — quarterly report dated 2025-09-30
Total revenue: 362611000
Gross profit: 90469000
Operating income: 5196000
Net income: -18727000
Capital expenditures: 8864000
Operating cash flow: 41017000
Depreciation & amortization: 32043000
Net tangible assets: -1913488000
Owner earnings: 4452000
Capex to operating income (%): 170.5927636643572
Buffett classification: The Gruesome
Stock price: 28.21
P/E ratio: 914.5964756701031
Shares outstanding: 97489954
Book value: 1128190000
P/B ratio: 2.4377025167214743
Market cap (USD): 2750191602.34
Debt to equity: 1.541584307607761
Current ratio: 1.1526310469900898
Quick ratio: 1.1526310469900898
COGS to revenue (%): 75.05067413840176
Free cash flow (dilution-adjusted): 10136000
Buyback yield (%): 0
Retained earnings: -219375000
Receivables turnover: 0.47552485151773854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.18334114897315196
FCF margin (%): 2.795281996409375
Revenue growth (%): -3.1260018380388557
Rule of 40 score: -0.33071984162948054
Financial ratios for BWIN — quarterly report dated 2025-12-31
Total revenue: 342897000
Gross profit: 90697000
Operating income: -15727000
Net income: -25861000
Capital expenditures: 10353000
Operating cash flow: 10269000
Depreciation & amortization: 40670000
Net tangible assets: -1895390000
Owner earnings: 4456000
Buffett classification: The Gruesome
Stock price: 24.03
Shares outstanding: 97489954
Book value: 1084398000
P/B ratio: 2.160354034791654
Market cap (USD): 2342683594.62
Debt to equity: 1.6326496360192475
Current ratio: 1.1616619543746853
Quick ratio: 1.1616619543746853
COGS to revenue (%): 73.54978317103969
Free cash flow (dilution-adjusted): -19425000
Buyback yield (%): 0
Retained earnings: -245236000
Receivables turnover: 0.4086139773657574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5558304411442466
FCF margin (%): -5.664966447650461
Revenue growth (%): -5.436680078651778
Rule of 40 score: -11.10164652630224
Financial ratios for BWIN — annual report dated 2025-12-31
Total revenue: 1488349000
Gross profit: 431107000
Operating income: 79530000
Net income: -33813000
Capital expenditures: 39527000
Operating cash flow: -29418000
Depreciation & amortization: 127830000
Net tangible assets: -1895390000
Owner earnings: 54490000
Capex to operating income (%): 49.700741858418205
Buffett classification: The Good
Stock price: 24.03
Shares outstanding: 97489954
Book value: 1084398000
P/B ratio: 2.160354034791654
Market cap (USD): 2342683594.62
Debt to equity: 1.6326496360192475
Current ratio: 1.1616619543746853
Quick ratio: 1.1616619543746853
COGS to revenue (%): 71.03454902042465
Free cash flow (dilution-adjusted): -140058000
Buyback yield (%): 0
Retained earnings: -245236000
Receivables turnover: 1.7735944163942747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.81078368310561
FCF margin (%): -9.410292881575492
Revenue growth (%): 8.14579983331432
Rule of 40 score: -1.2644930482611727
Financial ratios for CASA.V — annual report dated 2021-12-31
Total revenue: 0
Operating income: -725670.8661417323
Net income: -725670.8661417323
Capital expenditures: 15400.787401574802
Operating cash flow: -366785.0393700787
Net tangible assets: 2930135.433070866
Owner earnings: -741071.6535433071
Return on net tangible assets (%): -25.291378861851545
Buffett classification: The Gruesome
Stock price: 0.11023622047244096
Shares outstanding: 90563697
Book value: 2930135.4330708664
P/B ratio: 3.407146153250824
Market cap (USD): 9983399.66929134
Debt to equity: 0
Current ratio: 9.832895085149563
Quick ratio: 9.832895085149563
Free cash flow (dilution-adjusted): -730928.3464566929
Buyback yield (%): 0
Retained earnings: -2993798.42519685
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.765779013197637
Rule of 40 score: 0
Financial ratios for CASA.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -343885.29411764705
Net income: -368534.5588235294
Capital expenditures: 972155.1470588235
Operating cash flow: -262850
Net tangible assets: 2502529.4117647056
Owner earnings: -1340689.7058823528
Return on net tangible assets (%): -53.57338457560586
Buffett classification: The Gruesome
Stock price: 0.07352941176470588
Shares outstanding: 90563697
Book value: 2502529.411764706
P/B ratio: 2.660945895917072
Market cap (USD): 6659095.367647059
Debt to equity: 0
Current ratio: 1.2436991124156969
Quick ratio: 1.2436991124156969
Free cash flow (dilution-adjusted): -1235005.1470588234
Buyback yield (%): 0
Retained earnings: -3164213.970588235
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.741508591307616
Rule of 40 score: 0
Financial ratios for CASA.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -238006.0606060606
Net income: -210943.9393939394
Capital expenditures: 54756.81818181818
Operating cash flow: -263552.2727272727
Net tangible assets: 2496965.1515151514
Owner earnings: -265700.75757575757
Return on net tangible assets (%): -10.640947768715598
Buffett classification: The Gruesome
Stock price: 0.03787878787878788
Shares outstanding: 90563697
Book value: 2496965.1515151514
P/B ratio: 1.3738449918294755
Market cap (USD): 3430443.0681818184
Debt to equity: 0
Current ratio: 0.6055917439782971
Quick ratio: 0.6055917439782971
Free cash flow (dilution-adjusted): -263552.2727272727
Buyback yield (%): 0
Retained earnings: -3471043.1818181816
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.531813468107043
Rule of 40 score: 0
Financial ratios for CASA.V — quarterly report dated 2024-09-30
Total revenue: 0
Operating income: -46802.22222222222
Net income: -44422.96296296296
Capital expenditures: 16231.11111111111
Operating cash flow: 490.3703703703703
Net tangible assets: 2261271.8518518517
Owner earnings: -60654.07407407407
Return on net tangible assets (%): -2.682299079803336
Buffett classification: The Gruesome
Stock price: 0.029629629629629627
Shares outstanding: 90563697
Book value: 2261271.8518518517
P/B ratio: 1.1866635131916912
Market cap (USD): 2683368.8
Debt to equity: 0
Current ratio: 0.19131869125090384
Quick ratio: 0.19131869125090384
Free cash flow (dilution-adjusted): 490.3703703703703
Buyback yield (%): 0
Retained earnings: -3574114.0740740737
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.069730014279083
Rule of 40 score: 0
Financial ratios for CASA.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: 2583.916083916084
Net income: -4120.27972027972
Capital expenditures: 134.96503496503496
Operating cash flow: -22465.734265734267
Net tangible assets: 2130646.8531468534
Owner earnings: -4255.244755244755
Return on net tangible assets (%): -0.19971609790519637
Capex to operating income (%): 5.2232746955345055
Buffett classification: The Great
Stock price: 0.02097902097902098
Shares outstanding: 90563697
Book value: 2130646.8531468534
P/B ratio: 0.8917187268714153
Market cap (USD): 1899937.6993006994
Debt to equity: 0
Current ratio: 0.13493732782779502
Quick ratio: 0.13493732782779502
Free cash flow (dilution-adjusted): -22600.699300699303
Buyback yield (%): 0
Retained earnings: -3378283.916083916
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.12127378500570264
Rule of 40 score: 0
Financial ratios for CASA.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -163492.3076923077
Net income: -174244.05594405596
Capital expenditures: 21351.048951048953
Operating cash flow: -89388.11188811189
Net tangible assets: 2130646.8531468534
Owner earnings: -195595.10489510492
Return on net tangible assets (%): -9.180080903891756
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 90563697
Book value: 2130646.8531468534
P/B ratio: 0.8917187268714153
Market cap (USD): 1899937.6993006994
Debt to equity: 0
Current ratio: 0.13493732782779502
Quick ratio: 0.13493732782779502
Free cash flow (dilution-adjusted): -110739.16083916085
Buyback yield (%): 0
Retained earnings: -3378283.916083916
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.6733648962444505
Rule of 40 score: 0
Financial ratios for CASA.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -30229.37062937063
Net income: -30497.9020979021
Capital expenditures: 3612.587412587413
Operating cash flow: -16387.41258741259
Net tangible assets: 2274974.125874126
Owner earnings: -34110.48951048951
Return on net tangible assets (%): -1.499379229088289
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 90563697
Book value: 2274974.125874126
P/B ratio: 1.3919115809508937
Market cap (USD): 3166562.832167832
Debt to equity: 0
Current ratio: 0.562514118861679
Quick ratio: 0.562514118861679
Free cash flow (dilution-adjusted): -20000
Buyback yield (%): 0
Retained earnings: -3408781.8181818184
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3287786566695758
Rule of 40 score: 0
Financial ratios for CASA.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -40043.06569343065
Net income: -30877.37226277372
Capital expenditures: 161136.49635036496
Operating cash flow: -63764.23357664233
Net tangible assets: 2663537.226277372
Owner earnings: -192013.86861313868
Return on net tangible assets (%): -7.208980100552309
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 90563697
Book value: 2663537.2262773723
P/B ratio: 1.737292100455845
Market cap (USD): 4627342.182481752
Debt to equity: 0
Current ratio: 0.8899141882063125
Quick ratio: 0.8899141882063125
Free cash flow (dilution-adjusted): -224900.72992700728
Buyback yield (%): 0
Retained earnings: -3617416.05839416
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5033792393957213
Rule of 40 score: 0
Financial ratios for CASA.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -39397.84172661871
Net income: -42983.453237410075
Capital expenditures: 206256.8345323741
Operating cash flow: 103940.28776978418
Net tangible assets: 2582229.496402878
Owner earnings: -249240.2877697842
Return on net tangible assets (%): -9.652135416971392
Buffett classification: The Gruesome
Stock price: 0.04316546762589928
Shares outstanding: 90563697
Book value: 2582229.496402878
P/B ratio: 1.5138950028961087
Market cap (USD): 3909224.330935252
Debt to equity: 0
Current ratio: 0.48974006487373023
Quick ratio: 0.48974006487373023
Free cash flow (dilution-adjusted): -102316.54676258993
Buyback yield (%): 0
Retained earnings: -3608350.3597122305
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5257296759060754
Rule of 40 score: 0
Financial ratios for CASA.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -168683.9416058394
Net income: -780018.9781021897
Capital expenditures: 354817.51824817515
Operating cash flow: -119476.64233576642
Net tangible assets: 1876729.9270072991
Owner earnings: -1134836.4963503648
Return on net tangible assets (%): -60.46882292541771
Buffett classification: The Gruesome
Stock price: 0.0656934306569343
Shares outstanding: 90563697
Book value: 1876729.927007299
P/B ratio: 3.170109808176981
Market cap (USD): 5949439.9489051085
Debt to equity: 0
Current ratio: 0.27268217332504374
Quick ratio: 0.27268217332504374
Free cash flow (dilution-adjusted): -474294.16058394156
Buyback yield (%): 0
Retained earnings: -4306256.934306569
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.988184137652075
Rule of 40 score: 0
Financial ratios for CASA.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -28647.44525547445
Net income: -645229.9270072993
Capital expenditures: 0
Operating cash flow: -144064.96350364963
Net tangible assets: 1876729.9270072991
Owner earnings: -645229.9270072993
Return on net tangible assets (%): -34.380542331746476
Buffett classification: The Gruesome
Stock price: 0.0656934306569343
Shares outstanding: 90563697
Book value: 1876729.927007299
P/B ratio: 3.170109808176981
Market cap (USD): 5949439.9489051085
Debt to equity: 0
Current ratio: 0.27268217332504374
Quick ratio: 0.27268217332504374
Free cash flow (dilution-adjusted): -124707.29927007298
Buyback yield (%): 0
Retained earnings: -4306256.934306569
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5264553968698467
Rule of 40 score: 0
Financial ratios for CRISIL.NS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.4068252048905
Shares outstanding: 73130017
Market cap (USD): 2662431746.149671
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRISIL.NS — annual report dated 2022-12-31
Total revenue: 334225012.07146305
Gross profit: 166310960.88845968
Operating income: 75756880.73394495
Net income: 68130130.37180106
Capital expenditures: 4694591.984548527
Operating cash flow: 55086914.534041524
Depreciation & amortization: 12471028.488652823
Net tangible assets: 156129888.94253984
Owner earnings: 75906566.87590536
Return on net tangible assets (%): 48.61757565448669
Capex to operating income (%): 6.196918272065267
Buffett classification: The Great
Stock price: 35.29683727667793
P/E ratio: 37.887177024367894
Shares outstanding: 73130017
Book value: 216318203.76629648
P/B ratio: 11.932691124221808
Market cap (USD): 2581258310.0896907
Debt to equity: 0.046574180515407536
Current ratio: 1.8660733206187752
Quick ratio: 1.8660733206187752
Effective tax rate (%): 23.977640086206893
Interest coverage ratio: 98.05781250000001
COGS to revenue (%): 50.23982201161547
SG&A to revenue (%): 5.295949030598977
Free cash flow (dilution-adjusted): 50118300.33800097
Buyback yield (%): 0
Retained earnings: 183568324.48092708
Receivables turnover: 3.6486696625067543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 33.25402713013989
FCF margin (%): 14.995376925077295
Rule of 40 score: 14.995376925077295
Financial ratios for CRISIL.NS — annual report dated 2023-12-31
Total revenue: 381472660.9963548
Gross profit: 191806804.37424058
Operating income: 94698663.42648846
Net income: 80004860.2673147
Capital expenditures: 7182260.024301337
Operating cash flow: 94815309.84204131
Depreciation & amortization: 12609963.54799514
Net tangible assets: 197267314.70230862
Owner earnings: 85432563.7910085
Return on net tangible assets (%): 43.30801781325646
Capex to operating income (%): 7.584330933959481
Buffett classification: The Great
Stock price: 50.92357229647631
P/E ratio: 46.54769341886429
Shares outstanding: 73130017
Book value: 266009720.53462943
P/B ratio: 13.999645201902469
Market cap (USD): 3724041707.7420416
Debt to equity: 0.021614609502754352
Current ratio: 2.1016711121888134
Quick ratio: 2.1016711121888134
Effective tax rate (%): 24.116630171718334
Interest coverage ratio: 212.94262295081967
COGS to revenue (%): 49.719383854856794
SG&A to revenue (%): 4.789585669146876
Free cash flow (dilution-adjusted): 87166464.15552855
Buyback yield (%): 0
Retained earnings: 221154313.4872418
Receivables turnover: 4.6692644040572295
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 33.77361188752096
FCF margin (%): 22.849989807359083
Revenue growth (%): 14.136479083973946
Rule of 40 score: 36.98646889133303
Financial ratios for CRISIL.NS — quarterly report dated 2024-12-31
Total revenue: 106412169.25049539
Gross profit: 52268329.64214943
Operating income: 31035085.674321014
Net income: 26190698.216575358
Capital expenditures: 0
Depreciation & amortization: 2426856.276955356
Net tangible assets: 230573493.4141508
Owner earnings: 28617554.493530713
Return on net tangible assets (%): 12.411467627863242
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 75.84765124140343
P/E ratio: 52.94570594135142
Shares outstanding: 73130017
Book value: 298964914.32567894
P/B ratio: 18.553147071470512
Market cap (USD): 5546740024.693904
Debt to equity: 0.09747272713094876
Current ratio: 2.0366902713749346
Quick ratio: 2.0366902713749346
Effective tax rate (%): 23.70199327651194
Interest coverage ratio: 133.125
COGS to revenue (%): 50.88124787766593
SG&A to revenue (%): 4.800035052743425
Buyback yield (%): 0
Retained earnings: 242021214.59377548
Receivables turnover: 1.6604703614107204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.200323436722508
Rule of 40 score: 0
Financial ratios for CRISIL.NS — annual report dated 2024-12-31
Total revenue: 379972024.7115048
Gross profit: 195947080.0792633
Operating income: 98072036.36787504
Net income: 79737731.67035784
Capital expenditures: 19934724.326844618
Operating cash flow: 89178225.9004546
Depreciation & amortization: 8153630.959319267
Net tangible assets: 230573493.4141508
Owner earnings: 67956638.30283248
Return on net tangible assets (%): 29.472875349453258
Capex to operating income (%): 20.32661405343729
Buffett classification: The Great
Stock price: 75.84765124140343
P/E ratio: 69.56230016204337
Shares outstanding: 73130017
Book value: 298964914.32567894
P/B ratio: 18.553147071470512
Market cap (USD): 5546740024.693904
Debt to equity: 0.09747272713094876
Current ratio: 2.0366902713749346
Quick ratio: 2.0366902713749346
Effective tax rate (%): 26.163826135762626
Interest coverage ratio: 208.7741935483871
COGS to revenue (%): 48.43118247243679
SG&A to revenue (%): 5.554362564344832
Free cash flow (dilution-adjusted): 68994055.25119478
Buyback yield (%): 0
Retained earnings: 242021214.59377548
Receivables turnover: 5.929136579421233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.073367612097083
FCF margin (%): 18.157667081827608
Revenue growth (%): -0.3933797722045252
Rule of 40 score: 17.764287309623082
Financial ratios for CRISIL.NS — quarterly report dated 2025-03-31
Total revenue: 95064297.40472293
Gross profit: 45135609.07177928
Operating income: 23641571.19476268
Net income: 18685994.85620762
Capital expenditures: 0
Depreciation & amortization: 3480243.1610942245
Owner earnings: 22166238.017301846
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 47.696463998132806
P/E ratio: 46.66654424696831
Shares outstanding: 73130017
Market cap (USD): 3488043223.02334
Effective tax rate (%): 29.669556034672418
Interest coverage ratio: 36.43783783783783
COGS to revenue (%): 52.52096706756192
SG&A to revenue (%): 4.327455175975799
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -10.664073409742684
Rule of 40 score: -10.664073409742684
Financial ratios for CRISIL.NS — quarterly report dated 2025-06-30
Total revenue: 98644980.10765271
Gross profit: 44494500.35104143
Operating income: 24231219.2838755
Net income: 20076058.974959046
Capital expenditures: 0
Depreciation & amortization: 3708167.5637725256
Net tangible assets: 257424526.0940791
Owner earnings: 23784226.53873157
Return on net tangible assets (%): 9.239300893202119
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 69.76562134331851
P/E ratio: 63.532901069081134
Shares outstanding: 73130017
Book value: 329576410.016382
P/B ratio: 15.480358787204604
Market cap (USD): 5101961074.852446
Debt to equity: 0.10580282330218423
Current ratio: 2.0344821264894595
Quick ratio: 2.0344821264894595
Effective tax rate (%): 23.736498199759968
Interest coverage ratio: 36.716312056737586
COGS to revenue (%): 54.89430855732961
SG&A to revenue (%): 4.300016606960689
Buyback yield (%): 0
Receivables turnover: 1.1032415950165548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.5952195168559005
Revenue growth (%): 3.766590403214705
Rule of 40 score: 3.766590403214705
Financial ratios for CRISIL.NS — quarterly report dated 2025-12-31
Total revenue: 120482343.7674056
Gross profit: 57941405.8148602
Operating income: 33916675.9496491
Net income: 26902083.101258773
Capital expenditures: 0
Depreciation & amortization: 3909992.2022947534
Net tangible assets: 224666369.6112287
Owner earnings: 30812075.303553525
Return on net tangible assets (%): 13.714591710754004
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 47.68853737328729
P/E ratio: 37.96712000142947
Shares outstanding: 73130017
Book value: 337912442.9096581
P/B ratio: 10.320612993070572
Market cap (USD): 3487463548.813635
Debt to equity: 0.09784600981064401
Current ratio: 1.8814971400149216
Quick ratio: 1.8814971400149216
Effective tax rate (%): 26.038221242190374
Interest coverage ratio: 60.29108910891088
COGS to revenue (%): 51.9087992455412
SG&A to revenue (%): 4.335364331481087
Buyback yield (%): 0
Retained earnings: 268386988.97181687
Receivables turnover: 1.5733529232067265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.887974217956351
Revenue growth (%): 22.137328869569902
Rule of 40 score: 22.137328869569902
Financial ratios for CRISIL.NS — annual report dated 2025-12-31
Total revenue: 406484348.89161193
Gross profit: 214898072.85284618
Operating income: 106625821.54394564
Net income: 85330288.51509413
Capital expenditures: 7482455.163194831
Operating cash flow: 84168430.43332963
Depreciation & amortization: 14316586.833017712
Net tangible assets: 224666369.6112287
Owner earnings: 92164420.184917
Return on net tangible assets (%): 41.02279319526186
Capex to operating income (%): 7.0174888735661005
Buffett classification: The Great
Stock price: 47.68853737328729
P/E ratio: 40.870171770211876
Shares outstanding: 73130017
Book value: 337912442.9096581
P/B ratio: 10.320612993070572
Market cap (USD): 3487463548.813635
Debt to equity: 0.09784600981064401
Current ratio: 1.8814971400149216
Quick ratio: 1.8814971400149216
Effective tax rate (%): 26.41806672238072
Interest coverage ratio: 43.07740774077408
COGS to revenue (%): 47.13250991364781
SG&A to revenue (%): 5.378993206376523
Free cash flow (dilution-adjusted): 75991979.50317478
Buyback yield (%): 0
Retained earnings: 268386988.97181687
Receivables turnover: 5.308191379485911
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.94164010228745
FCF margin (%): 18.694933694344492
Revenue growth (%): 6.977441089310904
Rule of 40 score: 25.672374783655396
Financial ratios for CTNM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.14
Shares outstanding: 32723877
Market cap (USD): 626335005.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTNM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.65
Shares outstanding: 32723877
Market cap (USD): 479404798.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTNM — annual report dated 2024-12-31
Total revenue: 0
Operating income: -50894000
Net income: -42258000
Capital expenditures: 494000
Operating cash flow: -32845000
Depreciation & amortization: 258000
Net tangible assets: 198066000
Owner earnings: -42494000
Return on net tangible assets (%): -21.454464673391698
Buffett classification: The Gruesome
Stock price: 14.65
Shares outstanding: 32723877
Book value: 198066000
P/B ratio: 2.420429543939899
Market cap (USD): 479404798.05
Debt to equity: 0.03160057758524936
Current ratio: 20.69260076198115
Quick ratio: 20.69260076198115
Free cash flow (dilution-adjusted): -40163000
Buyback yield (%): 0
Retained earnings: -117402000
Capitalized R&D asset: 62491030
ROCI (R&D-adjusted, %): -15.11571356022392
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CTNM — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -18110000
Net income: -15990000
Capital expenditures: 47000
Operating cash flow: -14412000
Depreciation & amortization: 78000
Net tangible assets: 184768000
Owner earnings: -15959000
Return on net tangible assets (%): -8.637318150329062
Buffett classification: The Gruesome
Stock price: 6.98
Shares outstanding: 32723877
Book value: 184768000
P/B ratio: 1.2362133132360584
Market cap (USD): 228412661.46
Debt to equity: 0.03248397990994112
Current ratio: 21.469884903341157
Quick ratio: 21.469884903341157
Free cash flow (dilution-adjusted): -17028000
Buyback yield (%): 0
Retained earnings: -133392000
Capitalized R&D asset: 13712000
ROCI (R&D-adjusted, %): -4.417474851456539
Rule of 40 score: 0
Financial ratios for CTNM — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -17902000
Net income: -16040000
Capital expenditures: 44000
Operating cash flow: -15661000
Depreciation & amortization: 79000
Net tangible assets: 171390000
Owner earnings: -16005000
Return on net tangible assets (%): -9.338351129004026
Buffett classification: The Gruesome
Stock price: 3.97
Shares outstanding: 32723877
Book value: 171390000
P/B ratio: 0.758001001750394
Market cap (USD): 129913791.69000001
Debt to equity: 0.03354921524009569
Current ratio: 24.513307457721098
Quick ratio: 24.513307457721098
Free cash flow (dilution-adjusted): -18123000
Buyback yield (%): 0
Retained earnings: -149432000
Capitalized R&D asset: 23250040
ROCI (R&D-adjusted, %): -6.584087741900543
Rule of 40 score: 0
Financial ratios for CTNM — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -14932000
Net income: -12792000
Capital expenditures: 98000
Operating cash flow: -12197000
Depreciation & amortization: 81000
Net tangible assets: 180470000
Owner earnings: -12809000
Return on net tangible assets (%): -7.097578544910512
Buffett classification: The Gruesome
Stock price: 11.75
Shares outstanding: 32723877
Book value: 180470000
P/B ratio: 2.130578792874162
Market cap (USD): 384505554.75
Debt to equity: 0.030437191777026654
Current ratio: 29.07200125766389
Quick ratio: 29.07200125766389
Free cash flow (dilution-adjusted): -14864000
Buyback yield (%): 0
Retained earnings: -162224000
Capitalized R&D asset: 24939170
ROCI (R&D-adjusted, %): -8.051722404395486
Rule of 40 score: 0
Financial ratios for CTNM — annual report dated 2025-12-31
Total revenue: 0
Operating income: -68059000
Net income: -59978000
Capital expenditures: 231000
Operating cash flow: -55312000
Depreciation & amortization: 323000
Net tangible assets: 260989000
Owner earnings: -59886000
Return on net tangible assets (%): -22.94579465034925
Buffett classification: The Gruesome
Stock price: 11.43
Shares outstanding: 32723877
Book value: 260989000
P/B ratio: 1.4331405312484433
Market cap (USD): 374033914.11
Debt to equity: 0.031610527646759055
Current ratio: 27.495587027914613
Quick ratio: 27.495587027914613
Free cash flow (dilution-adjusted): -65581000
Buyback yield (%): 0
Retained earnings: -177380000
Capitalized R&D asset: 86373730
ROCI (R&D-adjusted, %): -15.772372539782149
Rule of 40 score: 0
Financial ratios for CTNM — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -17115000
Net income: -15156000
Capital expenditures: 42000
Operating cash flow: -13042000
Depreciation & amortization: 85000
Net tangible assets: 260989000
Owner earnings: -15113000
Return on net tangible assets (%): -5.79066550697539
Buffett classification: The Gruesome
Stock price: 11.43
Shares outstanding: 32723877
Book value: 260989000
P/B ratio: 1.4331405312484433
Market cap (USD): 374033914.11
Debt to equity: 0.031610527646759055
Current ratio: 27.495587027914613
Quick ratio: 27.495587027914613
Free cash flow (dilution-adjusted): -15566000
Buyback yield (%): 0
Retained earnings: -177380000
Capitalized R&D asset: 24760430
ROCI (R&D-adjusted, %): -5.816164248478378
Rule of 40 score: 0
Financial ratios for CXAI — annual report dated 2021-12-31
Total revenue: 0
Operating income: -1497914
Net income: 9207884
Capital expenditures: 0
Operating cash flow: -595321
Owner earnings: 9207884
Buffett classification: The Gruesome
Stock price: 9.99
P/E ratio: 118.35245138731113
Shares outstanding: 109086651
Market cap (USD): 1089775643.49
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -595321
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXAI — annual report dated 2022-12-31
Total revenue: 8470000
Gross profit: 6406000
Operating income: -23469000
Net income: -29175000
Capital expenditures: 88000
Operating cash flow: -18895000
Depreciation & amortization: 4797000
Net tangible assets: 3615000
Owner earnings: -24466000
Return on net tangible assets (%): -676.7911479944675
Buffett classification: The Gruesome
Stock price: 10.07
Shares outstanding: 109086651
Book value: 23391000
P/B ratio: 46.96261705656022
Market cap (USD): 1098502575.57
Debt to equity: 0.030353554786028813
Current ratio: 1.5824561403508772
Quick ratio: 1.5824561403508772
COGS to revenue (%): 24.36835891381346
R&D to revenue (%): 110.07083825265644
SG&A to revenue (%): 196.77685950413223
Free cash flow (dilution-adjusted): -21017000
Buyback yield (%): 25.04338962129904
Retained earnings: 0
Receivables turnover: 5.257603972687772
Capitalized R&D asset: 9323000
ROCI (R&D-adjusted, %): -51.98766622473987
FCF margin (%): -248.1345926800472
Rule of 40 score: -248.1345926800472
Financial ratios for CXAI — annual report dated 2023-12-31
Capital expenditures: 0
Net tangible assets: -1475000
Buffett classification: The Gruesome
Stock price: 1.29
Shares outstanding: 109086651
Book value: 25398000
P/B ratio: 5.540663823529412
Market cap (USD): 140721779.79
Debt to equity: 0.1400897708480983
Current ratio: 0.8752423419930205
Quick ratio: 0.8752423419930205
Buyback yield (%): 0
Retained earnings: -57801000
Capitalized R&D asset: 6246410
Rule of 40 score: 0
Financial ratios for CXAI — quarterly report dated 2024-09-30
Capital expenditures: 4000
Buffett classification: The Gruesome
Stock price: 1.68
Shares outstanding: 109086651
Market cap (USD): 183265573.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXAI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.82
Shares outstanding: 109086651
Market cap (USD): 198537704.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CXAI — annual report dated 2024-12-31
Total revenue: 7142000
Gross profit: 5857000
Operating income: -13741000
Net income: -19408000
Capital expenditures: 30000
Operating cash flow: -7325000
Depreciation & amortization: 3202000
Net tangible assets: -8549000
Owner earnings: -16236000
Buffett classification: The Gruesome
Stock price: 1.82
Shares outstanding: 109086651
Book value: 15592000
P/B ratio: 12.733305850436121
Market cap (USD): 198537704.82
Debt to equity: 0.3583889173935351
Current ratio: 0.6116102280580511
Quick ratio: 0.6116102280580511
Interest coverage ratio: -7.825170842824601
COGS to revenue (%): 17.99215905908709
R&D to revenue (%): 89.33071968636236
SG&A to revenue (%): 146.8216185942313
Free cash flow (dilution-adjusted): -10186000
Buyback yield (%): 0
Retained earnings: -77209000
Receivables turnover: 4.023661971830986
Capitalized R&D asset: 9456590
ROCI (R&D-adjusted, %): -42.43197447927738
FCF margin (%): -142.62111453374405
Rule of 40 score: -142.62111453374405
Financial ratios for CXAI — quarterly report dated 2025-03-31
Total revenue: 1224000
Gross profit: 1074000
Operating income: -3745000
Net income: -1616000
Capital expenditures: 5000
Operating cash flow: -979000
Depreciation & amortization: 795000
Net tangible assets: -7861000
Owner earnings: -826000
Buffett classification: The Gruesome
Stock price: 0.9
Shares outstanding: 109086651
Book value: 15597000
P/B ratio: 6.294671148297749
Market cap (USD): 98177985.9
Debt to equity: 0.31358594601525935
Current ratio: 0.5697300771208226
Quick ratio: 0.5697300771208226
Interest coverage ratio: -101.21621621621621
COGS to revenue (%): 12.254901960784313
R&D to revenue (%): 120.58823529411764
SG&A to revenue (%): 217.32026143790847
Free cash flow (dilution-adjusted): -1608000
Buyback yield (%): 0
Retained earnings: -78825000
Receivables turnover: 1.4836363636363636
Capitalized R&D asset: 1476000
ROCI (R&D-adjusted, %): -12.906694091249065
FCF margin (%): -131.37254901960785
Rule of 40 score: -131.37254901960785
Financial ratios for CXAI — quarterly report dated 2025-06-30
Total revenue: 1223000
Gross profit: 1052000
Operating income: -4111000
Net income: -3139000
Capital expenditures: 11000
Operating cash flow: -3012000
Depreciation & amortization: 788000
Net tangible assets: -8465000
Owner earnings: -2362000
Buffett classification: The Gruesome
Stock price: 1.07
Shares outstanding: 109086651
Book value: 14310000
P/B ratio: 8.156723729559749
Market cap (USD): 116722716.57000001
Debt to equity: 0.5559748427672956
Current ratio: 0.8151051875081667
Quick ratio: 0.8151051875081667
Interest coverage ratio: -25.220858895705522
COGS to revenue (%): 13.982011447260835
R&D to revenue (%): 179.31316434995912
SG&A to revenue (%): 186.99918233851184
Free cash flow (dilution-adjusted): -3777000
Buyback yield (%): 0
Retained earnings: -81964000
Receivables turnover: 1.332244008714597
Capitalized R&D asset: 3181920
ROCI (R&D-adjusted, %): -12.51547998718568
Rosenberg metric: -0.014905149051490514
FCF margin (%): -308.8307440719542
Revenue growth (%): -0.08169934640522876
Rule of 40 score: -308.91244341835943
Financial ratios for CXAI — quarterly report dated 2025-09-30
Total revenue: 1114000
Gross profit: 991000
Operating income: -3825000
Net income: -3157000
Capital expenditures: 5000
Operating cash flow: -2759000
Depreciation & amortization: 781000
Net tangible assets: -6858000
Owner earnings: -2381000
Buffett classification: The Gruesome
Stock price: 0.74
Shares outstanding: 109086651
Book value: 15234000
P/B ratio: 5.298944580543521
Market cap (USD): 80724121.74
Debt to equity: 0.4504398056977813
Current ratio: 0.8942121708079155
Quick ratio: 0.8942121708079155
Interest coverage ratio: -35.74766355140187
COGS to revenue (%): 11.041292639138241
R&D to revenue (%): 132.40574506283662
SG&A to revenue (%): 238.59964093357272
Free cash flow (dilution-adjusted): -3636000
Buyback yield (%): 0
Retained earnings: -85121000
Receivables turnover: 4.0071942446043165
Capitalized R&D asset: 3431390
ROCI (R&D-adjusted, %): -16.09552882471093
Rosenberg metric: -0.02781577747378021
FCF margin (%): -326.3913824057451
Revenue growth (%): -8.912510220768603
Rule of 40 score: -335.3038926265137
Financial ratios for CXAI — annual report dated 2025-12-31
Total revenue: 4583000
Gross profit: 4005000
Operating income: -15429000
Net income: -13473000
Capital expenditures: 23000
Operating cash flow: -10381000
Depreciation & amortization: 3163000
Net tangible assets: -5279000
Owner earnings: -10333000
Buffett classification: The Gruesome
Stock price: 0.33
Shares outstanding: 109086651
Book value: 13982000
P/B ratio: 2.574638451580604
Market cap (USD): 35998594.83
Debt to equity: 0.9215419825489916
Current ratio: 2.22872525182355
Quick ratio: 2.22872525182355
Interest coverage ratio: -22.009985734664763
COGS to revenue (%): 12.611826314641064
R&D to revenue (%): 144.79598516255726
SG&A to revenue (%): 219.63779183940647
Free cash flow (dilution-adjusted): -13188000
Buyback yield (%): 0
Retained earnings: -90682000
Receivables turnover: 4.739400206825232
Capitalized R&D asset: 10910600
ROCI (R&D-adjusted, %): -34.9408148096903
Rosenberg metric: -0.290282131661442
FCF margin (%): -287.75910975343663
Revenue growth (%): -35.830299635956315
Rule of 40 score: -323.5894093893929
Financial ratios for CXAI — quarterly report dated 2025-12-31
Total revenue: 1022000
Gross profit: 888000
Operating income: -3748000
Net income: -5561000
Capital expenditures: 2000
Operating cash flow: -3631000
Depreciation & amortization: 799000
Net tangible assets: -5279000
Owner earnings: -4764000
Buffett classification: The Gruesome
Stock price: 0.33
Shares outstanding: 109086651
Book value: 13982000
P/B ratio: 2.574638451580604
Market cap (USD): 35998594.83
Debt to equity: 0.9215419825489916
Current ratio: 2.22872525182355
Quick ratio: 2.22872525182355
Interest coverage ratio: -9.51269035532995
COGS to revenue (%): 13.111545988258316
R&D to revenue (%): 145.98825831702544
SG&A to revenue (%): 240.80234833659492
Free cash flow (dilution-adjusted): -4167000
Buyback yield (%): 0
Retained earnings: -90682000
Receivables turnover: 1.0568769389865564
Capitalized R&D asset: 3203940
ROCI (R&D-adjusted, %): -13.308367870600893
Rosenberg metric: -0.06983050847457627
FCF margin (%): -407.7299412915851
Revenue growth (%): -8.258527827648116
Rule of 40 score: -415.9884691192332
Financial ratios for CYPH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.4
Shares outstanding: 106464482
Market cap (USD): 3449449216.7999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYPH — annual report dated 2022-12-31
Total revenue: 0
Operating income: -54712000
Net income: -54596000
Capital expenditures: 0
Operating cash flow: -49044000
Depreciation & amortization: 16000
Net tangible assets: 58866000
Owner earnings: -54580000
Return on net tangible assets (%): -92.71905684096082
Buffett classification: The Gruesome
Stock price: 4.5
Shares outstanding: 106464482
Book value: 58866000
P/B ratio: 8.138656762817245
Market cap (USD): 479090169
Debt to equity: 0.011517684231984507
Current ratio: 6.0534521158129175
Quick ratio: 6.0534521158129175
Interest coverage ratio: -1013.1851851851852
Free cash flow (dilution-adjusted): -54224000
Buyback yield (%): 0
Retained earnings: -318168000
Receivables turnover: 0
Capitalized R&D asset: 44965000
ROCI (R&D-adjusted, %): -23.76272499911938
Rule of 40 score: 0